146 related articles for article (PubMed ID: 17555844)
1. Unconventional binding sites and receptors for VIP and related peptides PACAP and PHI/PHM: an update.
Muller JM; Debaigt C; Goursaud S; Montoni A; Pineau N; Meunier AC; Janet T
Peptides; 2007 Sep; 28(9):1655-66. PubMed ID: 17555844
[TBL] [Abstract][Full Text] [Related]
2. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
García-Fernández MO; Collado B; Bodega G; Cortés J; Ruíz-Villaespesa A; Carmena MJ; Prieto JC
Gynecol Endocrinol; 2005 Jun; 20(6):327-33. PubMed ID: 16019382
[TBL] [Abstract][Full Text] [Related]
5. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
[TBL] [Abstract][Full Text] [Related]
6. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain.
Joo KM; Chung YH; Kim MK; Nam RH; Lee BL; Lee KH; Cha CI
J Comp Neurol; 2004 Aug; 476(4):388-413. PubMed ID: 15282712
[TBL] [Abstract][Full Text] [Related]
7. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
8. PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures.
Dejda A; Jozwiak-Bebenista M; Nowak JZ
Ann N Y Acad Sci; 2006 Jul; 1070():220-5. PubMed ID: 16888170
[TBL] [Abstract][Full Text] [Related]
9. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
10. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
11. Role of VIP and PACAP in islet function.
Winzell MS; Ahrén B
Peptides; 2007 Sep; 28(9):1805-13. PubMed ID: 17559974
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical antagonism of PACAP receptor signaling by VIP in Xenopus oocytes via the type-C natriuretic peptide receptor.
Lelièvre V; Hu Z; Ioffe Y; Byun JY; Flores A; Seksenyan A; Waschek JA
Cell Signal; 2006 Nov; 18(11):2013-21. PubMed ID: 16723209
[TBL] [Abstract][Full Text] [Related]
13. Expression and GTP sensitivity of peptide histidine isoleucine high-affinity-binding sites in rat.
Debaigt C; Meunier AC; Goursaud S; Montoni A; Pineau N; Couvineau A; Laburthe M; Muller JM; Janet T
Ann N Y Acad Sci; 2006 Jul; 1070():215-9. PubMed ID: 16888169
[TBL] [Abstract][Full Text] [Related]
14. Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys.
Aubert N; Basille M; Falluel-Morel A; Vaudry D; Bucharles C; Jolivel V; Fisch C; De Jouffrey S; Le Bigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Comp Neurol; 2007 Oct; 504(4):427-39. PubMed ID: 17663433
[TBL] [Abstract][Full Text] [Related]
15. Newly-identified receptors for peptide histidine-isoleucine and GHRH-like peptide in zebrafish help to elucidate the mammalian secretin superfamily.
Wu S; Roch GJ; Cervini LA; Rivier JE; Sherwood NM
J Mol Endocrinol; 2008 Nov; 41(5):343-66. PubMed ID: 18757498
[TBL] [Abstract][Full Text] [Related]
16. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
[TBL] [Abstract][Full Text] [Related]
17. Calmodulin interacts with PAC1 and VPAC2 receptors and regulates PACAP-induced FOS expression in human neuroblastoma cells.
Falktoft B; Georg B; Fahrenkrug J
Neuropeptides; 2009 Apr; 43(2):53-61. PubMed ID: 19269029
[TBL] [Abstract][Full Text] [Related]
18. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development.
Basille M; Cartier D; Vaudry D; Lihrmann I; Fournier A; Freger P; Gallo-Payet N; Vaudry H; Gonzalez B
J Comp Neurol; 2006 Jun; 496(4):468-78. PubMed ID: 16572459
[TBL] [Abstract][Full Text] [Related]
19. The polypeptide PHI discriminates a GTP-insensitive form of VIP receptor in liver membranes.
Pineau N; Lelievre V; Goursaud S; Hilairet S; Waschek JA; Janet T; Muller JM
Neuropeptides; 2001 Apr; 35(2):117-26. PubMed ID: 11384207
[TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP formation in C6 glioma cells: effect of PACAP and VIP in early and late passages.
Sokolowska P; Nowak JZ
Ann N Y Acad Sci; 2006 Jul; 1070():566-9. PubMed ID: 16888226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
